Kirkbride P, Plowman P N
Department of Radiotherapy, St Bartholomew's Hospital, West Smithfield, London, UK.
Br J Radiol. 1992 Jun;65(774):510-6. doi: 10.1259/0007-1285-65-774-510.
Despite an improving overall survival rate for children with Wilms' tumour, four out of seven patients with bilateral tumours died in the period from 1952 to 1960 and five out of eight died in the period from 1971 to 1989, at St Bartholomew's Hospital and the Hospital for Sick Children. More aggressive chemotherapy with both adriamycin and actinomycin D and concern over young age being predisposed to late radiation morbidity prompted us to keep radiotherapy dose prescriptions to the surviving kidney below the quoted renal radiation tolerance dose equivalent. In three long-term survivors treated with daily fractions up to 167 cGy and total doses of 1000-1200 cGy, we have found renal function and growth to be within the "normal" range at follow-up and the patients to be normotensive 6-8 years later. As four of the eight patients reported here died from local disease progression within the kidney (albeit despite slightly larger dose prescriptions), we discuss the potential for larger total doses to be delivered in this situation.
尽管威尔姆斯瘤患儿的总体生存率有所提高,但在1952年至1960年期间,圣巴塞洛缪医院和儿童医院的7例双侧肿瘤患儿中有4例死亡,在1971年至1989年期间,8例中有5例死亡。使用阿霉素和放线菌素D进行更积极的化疗,以及担心年幼易患晚期放射并发症,促使我们将对存活肾脏的放疗剂量处方保持在低于所引用的肾脏放射耐受剂量当量之下。在3例接受每日分次剂量高达167 cGy、总剂量为1000 - 1200 cGy治疗的长期存活者中,我们发现在随访时肾功能和生长处于“正常”范围内,且患者在6 - 8年后血压正常。由于此处报告的8例患者中有4例死于肾脏内的局部疾病进展(尽管剂量处方略大),我们讨论了在这种情况下给予更大总剂量的可能性。